Get started
Author

Florian Van Oers

ORCID: 0009-0001-5176-3214
Observed ORCID: 0009-0001-5176-3214
OpenAlex ID: A5123485461
The search for safe and effective CAR-T targets in AML
2026 · Florian Van Oers, Donovan Flumens, et al. · Blood Cancer Journal · 2
PDF
Strategies to eliminate native T cell receptors for adoptive T cell therapies
2026 · Donovan Flumens, Diana Campillo-Davo, et al. · Molecular Therapy · 1
Persistent Campylobacter jejuni enterocolitis after CAR T-cell therapy in a patient with hypogammaglobulinemic follicular lymphoma
2026 · Dina Oulkadi, Florian Van Oers, et al. · ASM Case Reports
Inflammatory mechanisms in the AML bone marrow niche: From pathogenesis to therapy
2026 · Toon Suls, Eva Lion, et al. · Cytokine & Growth Factor Reviews
Advances in ex vivo mRNA-based gene transfer for cell-based cancer immunotherapy
2026 · Florian Van Oers, Zoi Katana, et al. · Molecular Therapy — Nucleic Acids
Proteomics in Acute Myeloid Leukemia: Current Applications in Precision Medicine and Targeted Immunotherapy
2026 · Eva De Backer, Florian Van Oers, et al. · Technology in Cancer Research & Treatment
Author response for "Proteomics in Acute Myeloid Leukemia: current applications in precision medicine and targeted immunotherapy"
2026 · Eva De Backer, Florian Van Oers, et al.
Author response for "Proteomics in Acute Myeloid Leukemia: current applications in precision medicine and targeted immunotherapy"
2026 · Eva De Backer, Florian Van Oers, et al.
Works count: 8
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type